Screening Marine Microbial Metabolites as Promising Inhibitors of Borrelia garinii: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment

Figure 4

(a) 2D depiction of control (S-nitroso-L-homocysteine). (b) 3D interaction of ADI-control. (c) 2D interaction of ADI-control complex. (d) 2D depiction of CMNPD18759. (e) 3D interaction of ADI-CMNPD18759. (f) 2D interaction of ADI-CMNPD18759 complex. (g) 2D depiction of CMNPD24419. (h) 3D interaction of ADI-CMNPD24419. (i) 2D interaction of ADI-CMNPD24419 complex. (j) 2D depiction of CMNPD24876. (k) 3D interaction of ADI-CMNPD24876. (l) 2D interaction of ADI-CMNPD24876 complex. (m) 2D depiction of CMNPD8737. (n) 3D interaction of ADI-CMNPD8737. (o) 2D interaction of ADI-CMNPD8737 complex. (p) 2D depiction of CMNPD23643. (q) 3D interaction of ADI-CMNPD23643. (r) 2D interaction of ADI-CMNPD23643 complex.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)